Join
Live feed
·
PRReleasevia Quantisnow
Akebia Therapeutics Inc. logo
Q32 Bio Inc. logo

Akebia Announces Establishment of Rare Kidney Disease Pipeline

ByQuantisnow·Wall Street's wire, on your screen.
AKBA· Akebia Therapeutics Inc.QTTB· Q32 Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKBA (Akebia Therapeutics Inc.), QTTB (Q32 Bio Inc.) and more on Quantisnow.

Akebia Announces Establishment of Rare Kidney Disease Pipeline | Quantisnow